ETF Holdings Breakdown of COLL

COLL institutional holdings

Date	ETF ISIN/Name	Num Shares	Book value
2025-09-26	IE00BF4RFH31 (iShares MSCI World Small Cap UCITS ETF USD (Acc))	28,654	USD 985,984
2025-09-26	IE00B3VWM098 (iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc)	4,311	USD 148,342
2025-09-26	IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc))	17,865	USD 614,735
2025-09-26	IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist))	17,865	USD 614,735
2025-09-26	IE000T9EOCL3 (iShares MSCI World Small Cap ESG Enhanced UCITS ETF USD (Acc))	421	USD 14,487 -0.7%
Total =		69,116	USD 2,378,283

Book value of shares is calculated on the adjusted close price of each day (row).

News associated with COLL

Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at HC Wainwright

HC Wainwright upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) to a strong-buy rating in a report released on Monday morning, MarketBeat Ratings reports. The firm currently has $44.00 target price on the specialty pharmaceutical company’s stock. COLL has been the subject of several other reports. Wall Street Zen upgraded Collegium Pharmaceutical from a […] - 2025-08-14 03:00:52

Collegium Pharmaceutical (NASDAQ:COLL) Stock Rating Upgraded by Wall Street Zen

Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was upgraded by equities researchers at Wall Street Zen from a “buy” rating to a “strong-buy” rating in a research note issued to investors on Saturday. Separately, Piper Sandler reissued a “neutral” rating and set a $37.00 price objective (up previously from $36.00) on shares of Collegium Pharmaceutical […] - 2025-08-11 04:33:01

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Purchased by Universal Beteiligungs und Servicegesellschaft mbH

Universal Beteiligungs und Servicegesellschaft mbH lifted its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.4% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 124,671 shares of the specialty pharmaceutical company’s stock after purchasing an additional 2,895 […] - 2025-07-29 05:22:58

Victory Capital Management Inc. Sells 60,823 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Victory Capital Management Inc. cut its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 10.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 498,713 shares of the specialty pharmaceutical company’s stock after selling 60,823 shares during the quarter. Victory Capital […] - 2025-07-24 04:53:18

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Bank of New York Mellon Corp

Bank of New York Mellon Corp decreased its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.1% in the 1st quarter, HoldingsChannel reports. The institutional investor owned 242,261 shares of the specialty pharmaceutical company’s stock after selling 10,426 shares during the period. Bank of New York Mellon Corp’s holdings in Collegium Pharmaceutical were […] - 2025-07-23 04:42:46

Collegium Pharmaceutical (NASDAQ:COLL) to Repurchase $150.00 million in Outstanding Stock

Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) announced that its Board of Directors has approved a stock repurchase program on Monday, July 7th, RTT News reports. The company plans to buyback $150.00 million in outstanding shares. This buyback authorization allows the specialty pharmaceutical company to repurchase up to 15.4% of its shares through open market […] - 2025-07-09 02:16:45

Collegium Pharmaceutical Breaks Above 200-Day Moving Average - Bullish for COLL

In trading on Monday, shares of Collegium Pharmaceutical Inc (Symbol: COLL) crossed above their 200 day moving average of $31.15, changing hands as high as $31.83 per share. Collegium Pharmaceutical Inc shares are currently trading up about 4.2% on the day. The chart below sho - 2025-07-07 12:54:17

Principal Financial Group Inc. Sells 71,695 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Principal Financial Group Inc. decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.4% during the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,573,356 shares of the specialty pharmaceutical company’s stock after selling 71,695 shares during the quarter. Principal […] - 2025-07-07 05:54:48

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Illinois Municipal Retirement Fund

Illinois Municipal Retirement Fund lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 8.0% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 15,820 shares of the specialty pharmaceutical company’s stock after selling 1,384 shares during the quarter. Illinois Municipal Retirement Fund’s […] - 2025-07-04 05:19:14

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Ritholtz Wealth Management

Ritholtz Wealth Management lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 5.0% during the 1st quarter, Holdings Channel.com reports. The firm owned 32,108 shares of the specialty pharmaceutical company’s stock after selling 1,676 shares during the quarter. Ritholtz Wealth Management’s holdings in Collegium Pharmaceutical were worth $958,000 as of its most […] - 2025-06-18 05:56:50

Exchange Traded Concepts LLC Decreases Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Exchange Traded Concepts LLC cut its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 16.9% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 62,426 shares of the specialty pharmaceutical company’s stock after selling 12,669 shares during […] - 2025-06-18 05:18:59

Farther Finance Advisors LLC Raises Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Farther Finance Advisors LLC boosted its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 4.5% in the first quarter, Holdings Channel.com reports. The institutional investor owned 11,091 shares of the specialty pharmaceutical company’s stock after acquiring an additional 477 shares during the period. Farther Finance Advisors LLC’s holdings in Collegium Pharmaceutical were worth […] - 2025-06-18 04:30:54

California State Teachers Retirement System Has $862,000 Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

California State Teachers Retirement System reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.8% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 30,093 shares of the specialty pharmaceutical company’s stock after selling 856 shares during the period. California State Teachers Retirement System’s holdings in Collegium Pharmaceutical were […] - 2025-06-11 05:04:51

Wellington Management Group LLP Lowers Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Wellington Management Group LLP reduced its stake in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 22.7% during the 4th quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 88,591 shares of the specialty pharmaceutical company’s stock after selling 26,049 shares during the period. Wellington Management Group […] - 2025-06-06 05:04:54

Bank of America Corp DE Trims Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Bank of America Corp DE decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 29.5% during the 4th quarter, HoldingsChannel.com reports. The firm owned 86,096 shares of the specialty pharmaceutical company’s stock after selling 36,093 shares during the period. Bank of America Corp DE’s holdings in Collegium Pharmaceutical were worth […] - 2025-06-02 04:38:48

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Purchased by ProShare Advisors LLC

ProShare Advisors LLC boosted its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 28.8% in the 4th quarter, Holdings Channel reports. The fund owned 11,196 shares of the specialty pharmaceutical company’s stock after acquiring an additional 2,506 shares during the quarter. ProShare Advisors LLC’s holdings in Collegium Pharmaceutical were worth $321,000 […] - 2025-05-30 05:06:52

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Receives $43.80 Average Price Target from Brokerages

Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Get Free Report) has been given a consensus rating of “Moderate Buy” by the five ratings firms that are covering the company, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12-month price […] - 2025-05-21 03:14:51

Voya Investment Management LLC Cuts Stock Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Voya Investment Management LLC lessened its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 7.4% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 9,923 shares of the specialty pharmaceutical company’s stock after selling 789 shares during the period. Voya […] - 2025-05-13 04:32:48

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Stake Reduced by Hsbc Holdings PLC

Hsbc Holdings PLC decreased its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 3.3% in the 4th quarter, HoldingsChannel.com reports. The firm owned 16,879 shares of the specialty pharmaceutical company’s stock after selling 576 shares during the period. Hsbc Holdings PLC’s holdings in Collegium Pharmaceutical were worth $483,000 at the end […] - 2025-05-07 05:00:51

Barclays PLC Grows Position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Barclays PLC increased its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 6.3% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 79,754 shares of the specialty pharmaceutical company’s stock after purchasing an additional 4,702 shares during the […] - 2025-05-01 05:14:59

Raymond James Financial Inc. Buys New Shares in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Raymond James Financial Inc. bought a new stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 84,883 shares of the specialty pharmaceutical company’s stock, valued at approximately $2,432,000. Other hedge funds and […] - 2025-04-30 05:10:55

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Sold by Legal & General Group Plc

Legal & General Group Plc lessened its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 1.2% during the 4th quarter, Holdings Channel.com reports. The fund owned 91,309 shares of the specialty pharmaceutical company’s stock after selling 1,084 shares during the period. Legal & General Group Plc’s holdings in Collegium Pharmaceutical were […] - 2025-04-24 06:31:01

Russell Investments Group Ltd. Decreases Stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Russell Investments Group Ltd. reduced its stake in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 31.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,649 shares of the specialty pharmaceutical company’s stock after selling 6,223 shares […] - 2025-04-24 04:48:48

JPMorgan Chase & Co. Cuts Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

JPMorgan Chase & Co. lowered its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 70.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 82,691 shares of the specialty pharmaceutical company’s stock after selling 194,513 shares during the […] - 2025-04-24 04:16:59

Collegium Pharmaceutical (NASDAQ:COLL) Rating Lowered to Buy at StockNews.com

Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research report issued to clients and investors on Saturday. A number of other analysts also recently weighed in on the stock. Needham & Company LLC reissued a “buy” rating and set a […] - 2025-04-21 02:22:45

Collegium Pharmaceutical, Inc. (NASDAQ:COLL) Shares Bought by Invesco Ltd.

Invesco Ltd. grew its position in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 19.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,775,760 shares of the specialty pharmaceutical company’s stock after acquiring an additional 289,335 shares during the quarter. Invesco Ltd. owned about […] - 2025-04-16 04:47:00

Collegium Pharmaceutical (NASDAQ:COLL) Upgraded at StockNews.com

StockNews.com upgraded shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) from a buy rating to a strong-buy rating in a research report report published on Friday morning. A number of other equities research analysts also recently weighed in on COLL. Needham & Company LLC reaffirmed a “buy” rating and issued a $46.00 target price on […] - 2025-04-14 02:58:57

Vanguard Group Inc. Sells 63,876 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Vanguard Group Inc. cut its holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 2.7% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 2,282,666 shares of the specialty pharmaceutical company’s stock after selling 63,876 shares during the period. Vanguard Group Inc. […] - 2025-04-11 06:16:58

Corebridge Financial Inc. Sells 1,595 Shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

Corebridge Financial Inc. lowered its holdings in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 8.5% during the 4th quarter, HoldingsChannel reports. The fund owned 17,084 shares of the specialty pharmaceutical company’s stock after selling 1,595 shares during the period. Corebridge Financial Inc.’s holdings in Collegium Pharmaceutical were worth $489,000 as of its […] - 2025-04-09 04:38:48

American Century Companies Inc. Has $2.45 Million Stock Holdings in Collegium Pharmaceutical, Inc. (NASDAQ:COLL)

American Century Companies Inc. trimmed its position in shares of Collegium Pharmaceutical, Inc. (NASDAQ:COLL – Free Report) by 18.5% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 85,466 shares of the specialty pharmaceutical company’s stock after selling 19,447 […] - 2025-04-08 05:04:48

Back to Listing

Disclaimer